SeekingAlpha · Mar 6, 2026
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call Transcript
Nutex Health Inc. (NUTX) Q4 2025 Earnings Call March 6, 2026 10:30 AM ESTCompany ParticipantsJennifer Rodriguez - Investor & Public Relations...
NU
NASDAQ · NUTX
Nutex Health, Inc.
Healthcare · Medical - Healthcare Information Services
$216.50
Up+$4.19 (+1.97%)
Updated Oct 4, 2026, 5:03 PM
SID Score
7.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.13B
- P/E ratio
- 11.18
- Dividend yield
- 0.00%
- 52-week range
- $84.91 – $224.28
- Volume
- 297.13K
- Avg. volume
- 149.38K
Price performance · NUTX
NUTX price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
NUTX closed at $216.50 after 19 trading sessions, up 13.55% for the selected period.
- Last close
- $216.50
- Period change
- +13.55%
- Period low
- $190.66
- Period high
- $220.11
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $217.38 | $221.01 | $212.59 | $216.50 | 297.13K |
| Oct 1, 2026 | $211.57 | $219.9399 | $210.195 | $212.31 | 122.53K |
| Sep 30, 2026 | $210.00 | $213.59 | $209.4868 | $211.66 | 147.84K |
| Sep 29, 2026 | $215.10 | $215.10 | $206.34 | $210.10 | 147.66K |
| Sep 28, 2026 | $218.15 | $222.13 | $209.00 | $212.735 | 163.48K |
| Sep 25, 2026 | $205.00 | $222.00 | $205.00 | $220.11 | 211.24K |
| Sep 24, 2026 | $201.01 | $205.99 | $198.25 | $204.59 | 136.83K |
| Sep 23, 2026 | $206.14 | $210.025 | $199.92 | $201.86 | 110.44K |
| Sep 22, 2026 | $201.92 | $212.13 | $201.92 | $208.82 | 158.21K |
| Sep 21, 2026 | $209.61 | $212.27 | $201.10 | $201.48 | 115.52K |
| Sep 18, 2026 | $213.94 | $216.95 | $203.87 | $208.79 | 246.79K |
| Sep 17, 2026 | $216.83 | $220.9199 | $212.97 | $214.32 | 108.6K |
| Sep 16, 2026 | $216.04 | $224.2799 | $214.275 | $217.325 | 146.85K |
| Sep 15, 2026 | $218.00 | $218.00 | $208.00 | $215.33 | 126.54K |
| Sep 14, 2026 | $199.47 | $219.00 | $198.28 | $217.02 | 244.43K |
| Sep 11, 2026 | $196.00 | $202.50 | $195.59 | $200.24 | 137.04K |
| Sep 10, 2026 | $197.21 | $198.51 | $190.00 | $195.20 | 90.53K |
| Sep 9, 2026 | $191.01 | $200.00 | $184.0001 | $197.68 | 184.24K |
| Sep 8, 2026 | $193.00 | $196.50 | $185.53 | $190.66 | 201.95K |
Latest NUTX news
The latest Smart Investors Daily articles mentioning NUTX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NUTX research
Overview
Company profile and research snapshot.
Company profile
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $205.00
- Implied upside
- —
- Analysts
- 9
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 25, 2026 | Freedom Capital Markets | Buy | — |
| Sep 4, 2026 | B. Riley Securities | Buy | — |
| Aug 11, 2026 | Lake Street | Buy | — |
| Jun 26, 2026 | B. Riley Securities | Buy | — |
| Jun 2, 2026 | Lake Street | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Mar 6, 2026
Nutex Health shares are trading lower after the company reported worse-than-expected Q4 financial results.
Benzinga · Mar 6, 2026
Market-Moving News for March 6th
MRVL: 15% | Marvell Technology shares are trading higher after the company reported better-than-expected Q4 financial results. IOT: 15% | Samsara shares are trading higher after the company
Benzinga · Mar 5, 2026
Nutex Health Announces $25M Share Buyback; Dates Not Disclosed
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
